Search results
Showing 601 to 615 of 672 results for kidney or kidneys or renal
Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTG751)
Late stage assessment (LSA) guidance on topical antimicrobial dressings for locally infected leg ulcers.
View recommendations for HTG751Show all sections
Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers.
Anaemia management in people with chronic kidney disease (CG114)
This guideline has been updated and replaced by NICE guideline NG8.
Chronic kidney disease in adults: assessment and management (CG182)
This guidance has been updated and replaced by NICE guideline NG203.
Anaemia management in people with chronic kidney disease (CG39)
This guideline has been updated and replaced by NICE guideline CG114.
NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .
Lenalidomide plus dexamethasone for previously untreated multiple myeloma (TA587)
Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for previously untreated multiple myeloma in adults.
include disease specific survival and toxicity, including the development of renal stones and hypercalcaemia. Any explanatory notes(if...
Evidence-based recommendations on sacubitril valsartan (Entresto) for treating symptomatic chronic heart failure with reduced ejection fraction.
COVID-19 rapid guideline: acute kidney injury in hospital (NG175)
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (HTG320)
Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis) and non-inflammatory bowel diseases (such as irritable bowel syndrome).
Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)
This guidance has been updated and replaced by NICE guideline NG203.
NICE has developed a medtech innovation briefing (MIB) on End-tidal Control software for use with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia .
The geko device for reducing the risk of venous thromboembolism (HTG344)
Evidence-based recommendations on the geko device for reducing the risk of venous thromboembolism.
This evidence summary has been updated and replaced by NICE guideline NG203.